Webinars

Conducting burden of illness studies and cost-effectiveness research is challenging without data that captures a patient’s complete journey from primary care to specialty clinics and inpatient care.

The benefits of leveraging real-world data (RWD) in clinical research are increasingly recognized and endorsed by regulators. As with any innovation, there is a gap between RWD availability and effectively leveraging the data, especially in the context of a randomized controlled trial (RCT).  One answer to this conundrum is to tokenize clinical trials data to enable connectivity to RWD. This webinar will focus on the operational processes to implement tokenization within a clinical trial to enable the ability to link to real–world data to answer research questions which could not previously be answered from traditional RCT designs.

Conducting burden of illness studies and cost-effectiveness research is challenging without data that captures a patient’s complete journey from primary care to specialty clinics and inpatient care.

You may know you need “HIPAA compliance” to share data, but do you know how to get it, as quickly as your business needs it?

Clinical trial data can be tokenized and connected to valuable, fit for purpose real-world data (RWD) in a privacy-preserving way before, during & after the trial.  

This webinar examines how enriching oncology clinical trials with real-world data generates deeper insights and improves operational efficiency to achieve better patient outcomes.

In this webinar, viewers will learn about what Datavant does and how you can enrich your dataset to get a more complete picture of your patients.

Diversity in clinical trials and clinical research needs to be improved, however, life sciences companies continue to face obstacles.

Synthetic data is the latest breakthrough in privacy-protected health data. Join a panel with Carter Prince, Head of Growth at Syntegra, Jamie Gray, Chief Operating Officer at Mirador Analytics, Su Huang, Head of Data Strategy at Datavant, and Ofer Mendelevitch, Chief Technology Officer at Syntegra in a conversation about situations where maintaining patient privacy calls for an entirely new approach – Synthetic Data. Learn more about what it is, how it’s created and when it makes sense to employ synthetic data in your health data strategy.